Detrusor Hyperreflexia
5 clinical trials · Condition
◉ Watch Detrusor Hyperreflexia
| Record | Firm | Date |
|---|---|---|
| Oral vs Intravesical Analgesia for Office Bladder Botox Injections (NCT03755089) | Women and Infants Hospital of Rhode Island | 2018-11-01 |
| Over Active Bladder Instillation Study - Botox (NCT00667095) | Mayo Clinic | 2008-04-01 |
| Botulin-A Toxin Instillations and Overactive Bladder (NCT00583219) | Mayo Clinic | 2006-03-01 |
| A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition (NCT00224029) | Watson Pharmaceuticals | 2004-12-01 |
| Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition (NCT00224016) | Watson Pharmaceuticals | 2004-12-01 |
Track Detrusor Hyperreflexia automatically
Every clearance here is in the API, with alerts when new ones post.